NWRD06 DNA Plasmid for HCC After Radical Resection

Clinical trial NCT06088459 · UNKNOWN

Trial details

NCT number: NCT06088459
Sponsor: Newish Technology (Beijing) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-11-01
Primary completion: 2024-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.